HK Stock Market Move | GAUSH MEDITECH (02407) rose more than 3%. The artificial intraocular lens implantation system obtained the medical device registration certificate.

GAUSH MEDITECH (02407) rose by more than 3%, with an increase of 3.33% to HKD 11.16 by the time of publication, with a turnover of HKD 1,128.09 million. On the news front, GAUSH MEDITECH announced that its fully-owned subsidiary Gaush Jing Medical Technology Co., Ltd. has obtained a Class II medical device registration certificate for its "artificial intraocular lens implantation system" from the Guangdong Provincial Food and Drug Administration. According to the announcement, the artificial intraocular lens implantation system approved this time (registration number: Yuezhonzhun 20242161490) was independently designed by Gaush Jing. It can be used for both cataract surgery with artificial intraocular lens implantation and for myopia correction with artificial intraocular lens implantation. This product can meet the needs of the group's single-focus and multi-focus artificial intraocular lenses, and can also be selected for adaptation by other lens manufacturers.